Deutsche Bank provided color on the pharmaceuticals sector. In a research report published today, Deutsche Bank named Pfizer PFE, Merck MRK and Bristol Myers Squibb BMY, all Buy-rated, as its top picks.
On Friday, BMY lost 0.45% of its value to finish the day at $28.97. Its shares continued to slide in today's pre-market trading, falling 0.28% to $28.89. At the same time, MRK lost 1.05% of its value on Friday to end the week at $35.93. Its shares continued to slide in today's pre-market trading, falling 0.72% to stand around $35.65. Finally, Pfizer lost 0.8% on Friday to close the day at $19.75. Its shares also continued to slide in today's pre-market trading, falling 0.46% of its value to stand around $19.66.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in